Mealey's (January 11, 2021, 2:57 PM EST) -- RICHMOND, Va. — The Fourth Circuit U.S. Court of Appeals on Jan. 6 vacated a $1.25 million Pradaxa fraud verdict after finding there was no newly discovered information about risks from...
4th Circuit Reverses $1.25M Pradaxa Verdict: No New Evidence To Escape Preemption
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login